Ketamine’s mechanisms of action in major depressive disorder and treatment-resistant depression: Is brain topological change a candidate convergent systems-level pathway?

This publication has 132 references indexed in Scilit:

• The molecular pathophysiology of depression and the new therapeutics
  Medcomm, 2022
• Eight‐week antidepressant treatment reduces functional connectivity in first‐episode drug‐naïve patients with major depressive disorder
  Human Brain Mapping, 2021
• Dynamic functional connectivity reveals altered variability in functional connectivity among patients with major depressive disorder
  Human Brain Mapping, 2016
• Neuronal correlates of depression
  Cellular and Molecular Life Sciences, 2015
• Large-Scale Network Dysfunction in Major Depressive Disorder
  JAMA Psychiatry, 2015
• Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression
  Brain Structure and Function, 2008
• A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression
  Archives of General Psychiatry, 2006
• Modulation of Cortical-Limbic Pathways in Major Depression
  Archives of General Psychiatry, 2004
• Ketamine and fMRI BOLD signal: Distinguishing between effects mediated by change in blood flow versus change in cognitive state
  Human Brain Mapping, 2002
• Functional and effective connectivity in neuroimaging: A synthesis
  Human Brain Mapping, 1994